Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 94
Titolo Data di pubblicazione Autore(i) File
5-Azacytidine, a DNA methyltransferase inhibitor, induces ATR-mediated DNA double-strand break responses, apoptosis, and synergistic cytotoxicity with doxorubicin and bortezomib against multiple myeloma cells. 1-gen-2007 T., Kiziltepe; T., Hideshima; L., Catley; N., Raje; H., Yasui; N., Shiraishi; Y., Okawa; H., Ikeda; S., Vallet; Pozzi, Samantha; K., Ishitsuka; E. M., Ocio; D., Chauhan; K. C., Anderson
MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts 1-gen-2007 S., Vallet; N., Raje; K., Ishitsuka; T., Hideshima; K., Podar; S., Chhetri; Pozzi, Samantha; I., Breitkreutz; T., Kiziltepe; H., Yasui; E. M., Ocio; N., Shiraishi; J., Jin; Y., Okawa; H., Ikeda; S., Mukherjee; N., Vaghela; D., Cirstea; M., Ladetto; M., Boccadoro; K. C., Anderson
Antiviral treatment with interferon +/- ribavirin after chemotherapy for diffuse large B-cell non-Hodgkin lymphomas with hepatitis C virus (HCV) infection 1-gen-2007 P., Musto; R., Guariglia; G., Pietrantuono; O., Villani; F., D'Auria; Luminari, Stefano; A., De Renzo; E., Iannitto; Pozzi, Samantha; Sacchi, Stefano
A Case-Control Study on the Role of an Antiviral Treatment with Interferon and Ribavirin after Conventional Chemotherapy in Diffuse Large B-Cell Lymphomas with Hepatitis C Virus (HCV) InfectionBlood (ASH Annual Meeting Abstracts), Nov 2008; 112: 3054 1-gen-2008 Roberto, Guariglia; Luminari, Stefano; Amalia De, Renzo; Emilio, Iannitto; Matteo, Dell’Olio; Pozzi, Samantha; Teresa, Pierri; Lucia, D’Amato; Antonio, Traficante; Sacchi, Stefano; Pellegrino, Musto
Anthracycline-Fludarabine Containing Regimens with or without Rituximab in the Treatment of Advanced Follicular Lymphoma Patients 1-gen-2008 Sacchi, Stefano; Marcheselli, Luigi; Pozzi, Samantha; Bari, Alessia; Luminari, Stefano; F., Ilariucci; C., Stelitano; F., Angrilli; A., Lazzaro; L., Baldini; M., Spriano; G., Caparrotti; M., Musso; G., Quarta; M., Brugiatelli
Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study 1-gen-2008 Sacchi, Stefano; Marcheselli, Luigi; Bari, Alessia; Marcheselli, Raffaella; Pozzi, Samantha; Gobbi, Pg; Angrilli, F; Brugiatelli, M; Musto, P; Federico, Massimo
Fatty acid synthase is a novel therapeutic target in multiple myeloma. 1-gen-2008 Y., Okawa; T., Hideshima; H., Ikeda; N., Raje; S., Vallet; T., Kiziltepe; H., Yasui; S., Enatsu; Pozzi, Samantha; I., Breitkreutz; D., Cirstea; L., Santo; P., Richardson; K. C., Anderson
Role of thalidomide in previously untreated patients with multiple myeloma 1-gen-2008 Musto, P; D'Auria, F; Pietrantuono, G; Bringhen, S; Morabito, F; Di Raimondo, F; Pozzi, Samantha; Sacchi, Stefano; Boccadoro, M; Palumbo, A.
Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: A 16-year follow-up study 1-gen-2008 Sacchi, Stefano; Marcheselli, Luigi; Bari, Alessia; Marcheselli, Raffaella; Pozzi, Samantha; Luminari, Stefano; Lombardo, M; Buda, G; Lazzaro, A; Gobbi, Pg; Stelitano, C; Morabito, F; Quarta, G; Brugiatelli, M.
AT7519, a Novel Small Molecule Multi-Cyclin Dependent Kinase Inhibitor, Induces Apoptosis in Multiple Myeloma VIA GSK3 beta 1-gen-2008 Santo, L; Vallet, S; Hideshima, T; Cirstea, D; Pozzi, S; Vaghela, N; Ikeda, H; Okawa, Y; Gorgun, G; Perrone, G; Calabrese, E; Squires, Ms; Ladetto, M; Munshi, Nc; Boccadoro, M; Anderson, Kc; Raje, N.
BISPHOSPHONATES (BP) RELATED OSTEONECROSIS OF THE JAW (ONJ): A LONG TERM FOLLOW UP (FU) OF A SERIES OF 35 CASES OBSERVED BY GISL 1-gen-2008 Pozzi, S.; Marcheselli, Raffaella; Sacchi, Stefano; Baldini, L.; Angrilli, F.; Falorio, S.; Quarta, G.; Stelitano, C.; Caparotti, G.; Luminari, Stefano; Falcone, A.; Natale, D.; Broglia, C. h.; Cuoghi, A.; Dini, D.; Ditonno, P.; Leonardi, G.; Pianezze, G.; Pitini, V.; Polimeno, G.; Ponchio, L.; Masini, L.; Maurizio, M.; Spriano, M.; Musto, P.
A Case-Control Study on the Role of an Antiviral Treatment with Interferon and Ribavirin after Conventional Chemotherapy in Diffuse Large B-Cell Lymphomas with Hepatitis C Virus (HCV) Infection 1-gen-2008 R., Guariglia; Luminari, Stefano; A., De Renzo; E., Iannitto; M., Dell'Olio; Pozzi, Samantha; T., Pierri; L., D'Amato; A., Traficante; Sacchi, Stefano; P., Musto
Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in mice 1-gen-2008 S., Mukherjee; N., Raje; J. A., Schoonmaker; J. C., Liu; T., Hideshima; M. N., Wein; D. C., Jones; S., Vallet; M. L., Bouxsein; Pozzi, Samantha; S., Chhetri; Y. D., Seo; J. P., Aronson; C., Patel; M. T., Fulciniti; L. E., Purton; L. H., Glimcher; J. B., Lian; G., Stein; K. C., Anderson; D. T., Scadden
A high-affinity fully human anti-IL-6 mAb (OP-R003-1, 1339) for the treatment of Multiple Myeloma 1-gen-2009 M. T., Fulciniti; T., Hideshima; C., Vermot Desroches; Pozzi, Samantha; P., Nanjappa; Z., Shen; N., Patel; E. S., Smith; R., Prabhala; Y., Tai; P., Tassone; K. C., Anderson; N. C., Munshi
High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties. 1-gen-2009 Pozzi, Samantha; S., Vallet; S., Mukherjee; D., Cirstea; N., Vaghela; L., Santo; E., Rosen; H., Ikeda; Y., Okawa; T., Kiziltepe; J., Schoonmaker; W., Xie; T., Hideshima; E., Weller; M. L., Bouxsein; N. C., Munshi; K. C., Anderson; N., Raje
Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myeloma. 1-gen-2009 N., Raje; T., Hideshima; S., Mukherjee; M., Raab; S., Vallet; S., Chhetri; D., Cirstea; Pozzi, Samantha; C., Mitsiades; M., Rooney; T., Kiziltepe; K., Podar; Y., Okawa; H., Ikeda; R., Carrasco; P. G., Richardson; D., Chauhan; N. C., Munshi; S., Sharma; H., Parikh; B., Chabner; D., Scadden; K. C., Anderson
Bisphosphonates-associated osteonecrosis of the jaw: A long-term follow-up of a series of 35 cases observed by GISL and evaluation of its frequency over time 1-gen-2009 Pozzi, Samantha; Marcheselli, Raffaella; Falorio, S; Masini, L; Stelitano, C; Falcone, A; Quarta, G; Ponchio, L; Pitini, V; Luminari, Stefano; Baldini, L; Gruppo Italiano Studio, Linfomi
The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells In vitro and In vivo 1-gen-2009 H., Ikeda; T., Hideshima; M. T., Fulciniti; R. J., Lutz; H., Yasui; Y., Okawa; T., Kiziltepe; S., Vallet; Pozzi, Samantha; L., Santo; G., Perrone; Y., Tai; D., Cirstea; N. S., Raje; C., Uherek; B., Dälken; S., Aigner; F., Osterroth; N., Munshi; P., Richardson; K. C., Anderson
Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story. 1-gen-2009 Bari, Alessia; Marcheselli, Luigi; Sacchi, Stefano; Marcheselli, Raffaella; Pozzi, Samantha; Ferri, Paola; Balleari, E; Musto, P; Neri, S; Aloe Spiriti, Ma; Cox, M. C.
Anthracycline-fludarabine-containing regimens with or without rituximab in the treatment of patients with advanced follicular lymphoma. 1-gen-2009 Luminari, Stefano; Marcheselli, Luigi; Sacchi, Stefano; Pozzi, Samantha; Bari, Alessia; F., Ilariucci; C., Stelitano; F., Angrilli; A., Lazzaro; L., Baldini
Mostrati risultati da 21 a 40 di 94
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile